MARKET

IDXX

IDXX

IDEXX Labs
NASDAQ

Real-time Quotes | Nasdaq Last Sale

520.17
+1.89
+0.36%
After Hours: 520.17 0 0.00% 16:52 02/26 EST
OPEN
522.90
PREV CLOSE
518.28
HIGH
526.37
LOW
507.34
VOLUME
593.64K
TURNOVER
--
52 WEEK HIGH
573.99
52 WEEK LOW
168.65
MARKET CAP
44.44B
P/E (TTM)
77.53
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Teleflex (TFX) Beats on Q4 Earnings and Revenues, Margins Fall
Zacks.com · 6h ago
NuVasive's (NUVA) Q4 Earnings Top Estimates, Margin Declines
Zacks.com · 8h ago
Tandem Diabetes' (TNDM) Q4 Earnings, Revenues Top Estimates
Zacks.com · 1d ago
Myriad Genetics (MYGN) Beats on Q2 Revenues, Earnings in Line
Zacks.com · 2d ago
Insulet (PODD) Q4 Earnings Fall Shy of Estimates, Revenues Beat
Zacks.com · 2d ago
Animal Healthcare Market size is poised to be worth CAGR of around 4.4%.
pune, India, Wed, 24 Feb 2021 06:10:50 / Comserve Inc. / -- Acumen Research and Consulting, Latest Research Study on "Animal Healthcare Market Size Share,...
Comserve · 2d ago
Veterinary Medical Equipment Global Market Report 2021: COVID 19 Impact and Recovery to 2030
Reportlinker.com announces the release of the report "Veterinary Medical Equipment Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027753/?utm_source=GNW
GlobeNewswire · 2d ago
Analog Veterinary X Ray System Market : Industry Report, Growth, Price, Trends and Forecast 2020-2027
Japan, Japan, Wed, 24 Feb 2021 01:46:57 / Comserve Inc. / -- Competitive Analysis: IDEXX Laboratories, Air Techniques, Canon, Agfa-Gevaert Group, Konica...
Comserve · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IDXX. Analyze the recent business situations of IDEXX Labs through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IDXX stock price target is 565.83 with a high estimate of 600.00 and a low estimate of 510.00.
EPS
Institutional Holdings
Institutions: 1.25K
Institutional Holdings: 84.48M
% Owned: 98.90%
Shares Outstanding: 85.43M
TypeInstitutionsShares
Increased
304
3.33M
New
198
138.94K
Decreased
317
3.14M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.63%
Key Executives
President/Chief Executive Officer
Jay Mazelsky
Non-Executive Chairman/Independent Director
Lawrence Kingsley
President/Chief Executive Officer/Director
Jonathan Mazelsky
President/Chief Executive Officer
Jonathan Jay Mazelsky
Chief Financial Officer/Executive Vice President/Treasurer
Brian McKeon
Chief Human Resource Officer/Vice President
Giovani Twigge
Executive Vice President/General Manager
Tina Hunt
Executive Vice President/General Manager
Michael Lane
Executive Vice President
James Polewaczyk
Chief Marketing Officer/Vice President
Kathy Turner
Vice President/General Counsel/Secretary
Sharon Underberg
Director
Jonathan Ayers
Independent Director
Bruce Claflin
Independent Director
Asha Collins
Independent Director
Stuart Essig
Independent Director
Rebecca Henderson
Independent Director
Daniel Junius
Independent Director
Sam Samad
Independent Director
M. Anne Szostak
Independent Director
Sophie Vandebroek
  • Dividends
  • Splits
  • Insider Activity
No Data
About IDXX
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include diagnostic and information technology-based products and services for the veterinary market, which the Company refers to as the Companion Animal Group; water quality products; diagnostic products and services for livestock and poultry health, which the Company refers to as Livestock, Poultry and Dairy, and Other operating segment, which combines and presents products for the human point-of-care medical diagnostics market with its pharmaceutical product line and its out-licensing arrangements. Its products and services include point-of-care veterinary diagnostic products, comprising instruments, consumables and rapid assay test kits, among others.

Webull offers kinds of IDEXX Laboratories, Inc. stock information, including NASDAQ:IDXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDXX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IDXX stock methods without spending real money on the virtual paper trading platform.